Join the club for FREE to access the whole archive and other member benefits.

Neutrobots wade through blood brain barrier to treat brain tumors in mice

Promising precision biomedicine in the near future with neutrophil-based drug carrier bots

24-Mar-2021

Key points from article :

Life-saving drugs will be parceled, smuggled, and transported in the body via tiny, self-propelled microbots.

A new kind of bio-hybrid microbot to provide the most targeted (and effective) treatment.

The target of choice? Hard to treat illness epicenters like brain tumors.

It can cross the body’s toughest biological barriers: the blood-brain barrier.

"The new microbots can overcome obstacles that have hindered conventional lines of medical treatment," - Zhiguang Wu, study author.

“Able to navigate into hard-to-reach tissues utilizing their active propulsion,” - Wu.

Surrounding magnetic field can precisely control the movement.

MRI and fluorescence imaging can track groups of the neutrobots as they move, but not individuals.

“Research verified the treatment of the neutrobots can extend the survival time of glioma-bearing mice,” - Wu.

Study by Harbin Institute of Technology published in Science Robotics.

Mentioned in this article:

Click on resource name for more details.

Harbin Institute of Technology (HIT)

Research university and a member of China's elite C9 League.

Science Robotics

Journal providing information in the field of robotics.

Zhiguang Wu

Postdoctoral researcher at the Max Planck Institute for Intelligent Systems

Topics mentioned on this page:
Nanobots